Simplex Trading
RLAY icon

Simplex Trading’s Relay Therapeutics RLAY Stock Holding History

Simplex Trading’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.6K Buy
8,200
+8,100
+8,100% +$72.5K ﹤0.01% 5325
2025
Q4 		$846 Buy
+100
New +$714 ﹤0.01% 8064
2025
Q1 		– Sell
-600
Closed -$2K – 9471
2024
Q4 		$2K Sell
600
-3,600
-86% -$19.6K ﹤0.01% 8069
2024
Q3 		$29K Buy
+4,200
New +$31.4K ﹤0.01% 6392
2024
Q2 		– Sell
-200
Closed -$1K – 9642
2024
Q1 		$1K Sell
200
-100
-33% -$976 ﹤0.01% 8634
2023
Q4 		$3K Sell
300
-100
-25% -$844 ﹤0.01% 8134
2023
Q3 		$3K Sell
400
-4,200
-91% -$45.2K ﹤0.01% 7945
2023
Q2 		$57K Sell
4,600
-1,500
-25% -$18.7K ﹤0.01% 5716
2023
Q1 		$100K Buy
+6,100
New +$109K ﹤0.01% 5159
2022
Q4 		– Sell
-1,800
Closed -$40K – 10222
2022
Q3 		$40K Buy
+1,800
New +$39.5K ﹤0.01% 6739
2021
Q2 		– Sell
-5
Closed -$17K – 10608
2021
Q1 		$17K Buy
+5
New +$217 ﹤0.01% 7592

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Simplex Trading's RLAY Position: Q3 2025 in Review

Simplex Trading sold out of Relay Therapeutics (RLAY) in Q3 2025, closing a stake of 2,984 shares — an estimated $11.4K sold.

Simplex Trading first reported a position in RLAY in Q1 2022 and held it in 12 quarters. The position peaked at $195K in Q4 2024. 199 funds tracked by Wall St. Rank hold RLAY as of Q3 2025.

  • Simplex Trading reported no remaining Relay Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 2,984 Relay Therapeutics shares in Q3 2025, an estimated $11.4K.
  • Simplex Trading first reported a position in Relay Therapeutics in Q1 2022 and held it in 12 quarters.
  • Simplex Trading's Relay Therapeutics position peaked at $195K in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.